Pulse Biosciences appoints Laureen DeBuono to board, Kenneth Clark resigns

PULSE BIOSCIENCES, INC.

Kenneth Clark resigned from Board on Oct 4; holds vested options for 150,574 shares at $10.66-$23.08.
Laureen DeBuono elected to Board; will serve on Audit Committee and chair Nominating Committee.
DeBuono received initial grant of 32,500 stock options; annual retainers: $40k board, $10k Audit, $10k Nominating Chair.
Chief Strategy Officer Mr. Levinson designated as an executive officer under the Exchange Act.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Laureen DeBuono

Director

PLSE · PULSE BIOSCIENCES, INC.

Effective: 2021-10-04
Filed: October 6, 2021, 7:59 PM ET

On October 4, 2021, the Board elected Laureen DeBuono to the Board, effective immediately, to fill the vacancy on the Board resulting from Mr. Clark’s resignation.

Departed

Kenneth A. Clark

Director

PLSE · PULSE BIOSCIENCES, INC.

Effective: 2021-10-04
Successor: Laureen DeBuono
Filed: October 6, 2021, 7:59 PM ET

On October 4, 2021, Kenneth A. Clark resigned from the Board of Directors (the “Board”) of Pulse Biosciences, Inc. (the “Company”) and from all committees of the Board for personal reasons.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Laureen DeBuono was elected as Director at PULSE BIOSCIENCES, INC..

Action: elected
Role: Director

Exact text from the filing

On October 4, 2021, the Board elected Laureen DeBuono to the Board, effective immediately, to fill the vacancy on the Board resulting from Mr. Clark’s resignation.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Kenneth A. Clark resigned as Director at PULSE BIOSCIENCES, INC..

Action: resigned
Role: Director

Exact text from the filing

On October 4, 2021, Kenneth A. Clark resigned from the Board of Directors (the “Board”) of Pulse Biosciences, Inc. (the “Company”) and from all committees of the Board for personal reasons.

View on SEC.gov

PULSE BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001625101-21-000050

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.